NEW YORK - Elan Corporation, which has a plant in Gainesville and has been wrangling with questions about off-balance-sheet accounting of special investments, says it has completed its audit of fiscal 2002. <br>
<br>
The Irish pharmaceutical company has also repeatedly missed filing deadlines with the Securities and Exchange Commission for the report - and says the filing, which is expected next year, will cure those defaults. <br>
<br>
The restatement will reduce Elan's diluted earnings per share for 2001 from 95 cents to 75 cents. For 2002, the adjustment will reduce Elan's diluted loss per share from $6.85 to $6.65.
